New Technologies
18F_rhPSMA_7.3_PET_image.jpg
New TechnologiesBlue Earth Diagnostics Receives FDA New Drug Application Acceptance for 18F-rhPSMA-7.3Blue Earth Diagnostics Receives FDA New Drug Application Acceptance for 18F-rhPSMA-7.3
The company milestone brings it one step closer to advancing its current prostate cancer portfolio.
Sign up for the QMED & MD+DI Daily newsletter.